SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-22-037402
Filing Date
2022-10-17
Accepted
2022-10-17 16:18:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20005397x3_defa14a.htm DEFA14A 11884
2 ny20005397x3_nc1.jpg GRAPHIC 1869421
3 ny20005397x3_nc2.jpg GRAPHIC 1171596
  Complete submission text file 0001140361-22-037402.txt   3918895
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37969 | Film No.: 221313925
SIC: 3845 Electromedical & Electrotherapeutic Apparatus